UF Startup Helping Veterinarians Take Animal Vital Signs Brings Its Product to the Zoo
Vik Ramprakash, founder of UF startup Structured Monitoring Products (SMP), is making the process of taking vital signs easier and safer. The company’s VetGuardian monitor remotely gathers vital signs, including temperature, pulse and respiration of sick, injured or post-operative animals.
AbFero to Receive € 2M Eurostars Funding for Parkinson’s Disease Therapy
AbFero Ltd., a subsidiary of UF startup AbFero Pharmaceuticals, Inc., a privately-held clinical-stage pharmaceutical company dedicated to treating diseases of iron overload, announced the funding of approximately € 2M from EUREKA Eurostars for the development of iron-chelating compounds including their lead agent, SP-420, as a disease-modifying therapy for Parkinson's disease.
Pets, Perseverance, and Manufacturing Facility Bring Biotech Success
Patricia Lawman, co-founder and CEO of the biotech firm Morphogenesis, a UF startup and UF Innovate | Sid Martin Biotech graduate company, has always been amazed at how our bodies can defeat illnesses and usually do it better than drugs.
Sun BioPharma, Inc. Changes Name to Panbela Therapeutics Inc.
UF startup Sun BioPharma, Inc., a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, has announced the change of its corporate name to Panbela Therapeutics, Inc. effective December 2, 2020.
TearClear Announces Successful Completion of Pre-IND Meeting With the FDA for a Preservative Free Multi-Dose Delivery of Latanoprost for the Treatment of Glaucoma
UF startup and UF Innovate | Sid Martin Biotech resident client TearClear, an emerging ophthalmic pharmaceutical company, announced successful completion of pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding the development plan for the preservative free multi-dose delivery of a proprietary Latanoprost formulation, including the clinical study design for the registration study.
UF Researcher Finds a Way to Mitigate Acute Respiratory Distress Syndrome (ARDS), a Complication of Coronavirus Infection
Why would a doctor specializing in gastrointestinal disorders be interested in therapy for COVID-19, a primarily pulmonary disease? The answer lies in a seemingly convoluted link between the gastrointestinal tract and the lungs: water.
Huvepharma Introduces New Necrotic Enteritis Vaccine Developed by Curtiss Healthcare, Inc.
Huvepharma, Inc., a pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health products, has introduced AVERT NE, an innovative new vaccine to help control necrotic enteritis (NE) due to Clostridium perfringens Type A.
Ology Bioservices Awarded $37 Million for Advanced Development of Anti-COVID-19 Monoclonal Antibody Cocktail
UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced that the Department of Defense (DOD) has awarded the company with an agreement valued at $37 million.
Cannabix Technologies to Beta Test Marijuana Breathalyzer to Meet Workplace Drug Testing Needs
UF startup Cannabix Technologies Inc., developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, reported that it plans to begin beta testing its version 3.0 THC Breath Analyzer.
Morphogenesis CEO Patricia Lawman Recognized As Health Care Innovator 2020 on Tampa Bay Business Journal
The Tampa Bay Business Journal recognized Patricia Lawman, founder and chief executive officer of UF startup and UF Innovate | Sid Martin Biotech graduate... Read More
